Sutton Wealth Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-259
Closed -$7.66K 1593
2022
Q4
$7.66K Sell
259
-138
-35% -$4.44K ﹤0.01% 1020
2022
Q3
$15.5K Hold
397
0.01% 743
2022
Q2
$15.3K Sell
397
-148
-27% -$5.63K 0.01% 757
2022
Q1
$26.4K Buy
545
+39
+8% +$2.01K 0.01% 618
2021
Q4
$37.2K Buy
506
+23
+5% +$1.89K 0.01% 506
2021
Q3
$44K Buy
+483
New +$41.1K 0.02% 430

Other funds holding ASTH

Sutton Wealth Advisors's ASTH Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Astrana Health (ASTH) in Q1 2023, closing a stake of 259 shares — an estimated $7.66K sold.

Sutton Wealth Advisors first reported a position in ASTH in Q3 2021 and held it in 6 quarters. The position peaked at $44K in Q3 2021. 133 funds tracked by Wall St. Rank hold ASTH as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Astrana Health position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 259 Astrana Health shares in Q1 2023, an estimated $7.66K.
  • Sutton Wealth Advisors first reported a position in Astrana Health in Q3 2021 and held it in 6 quarters.
  • Sutton Wealth Advisors's Astrana Health position peaked at $44K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Astrana Health as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.